Healthcare

Bet With Buffett on DaVita Real Money Pro($)

Using a "buy-write combination" could pay off for this slow performing stock.
Here's where to buy NVS.
Synergy Pharmaceuticals, Trevena and Egalet seem to have worst-case scenarios priced into them.
Consider protecting your profits.
The two aren't among today's hot names, but are solid long-term growth plays.
Favorable demographics of an aging population should offset the impact of new regulations or legislation covering skilled nursing reimbursement.

Intermediate Trade: Pfizer Real Money Pro($)

The tactic here is a synthetic call expiring in June of next year.
But there is hope, as the FDA has approved almost as many new compounds in 2017 as in all of 2016.
Valuations in some large-caps are compelling over the long term.
Flexion Therapeutics and BioDelivery Sciences are well below what they once fetched.

Columnist Conversations

this stock is showing great relative strength today, superior volume and strong price action. BOUGHT ...
If we can answer that question above we will know when this market finally corrects. The Dippers showed up aga...
If GM goes ahead with borrowing an additional $3 billion to fund the pensions... 1)  They will be tran...
I see many people negative on Nasdaq and the FANG stocks today. I have written about these stocks quite often ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.